Physician profile
Susan Baser
NPI 1659370559
$20,195.41
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $6,746 · 2021: $467 · 2022: $177 · 2023: $385 · 2024: $21.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adamas Pharmaceuticals, INC. | $11,274.79 | 2019-2020 | |
| Mdd US Operations, LLC | $7,118.17 | 2019 | |
| Acorda Therapeutics, INC | $725.00 | 2019 | |
| Neurocrine Biosciences, INC. | $513.17 | 2021-2023 | Ongentys, Ingrezza |
| Teva Pharmaceuticals USA, INC. | $227.33 | 2022-2023 | Austedo, Austedo Xr |
| Kyowa Kirin, INC. | $107.64 | 2023 | Nourianz |
| Acadia Pharmaceuticals INC | $89.14 | 2023 | Nuplazid |
| Xeris Pharmaceuticals, INC. | $46.51 | 2023-2024 | Keveyis |
| Amgen INC. | $29.59 | 2022 | |
| Zimmer Biomet Holdings, INC. | $26.48 | 2020 | |
| Avion Pharmaceuticals | $21.50 | 2023 | Dhivy |
| Pfizer INC. | $16.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Baser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.